AIG
AIM

American International Group’s AIM ImmunoTech AIM Stock Holding History

American International Group’s Portfolio AIM Stock Details AIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-5
Closed -$66.1K – 5350
2015
Q1 		$66.1K Buy
+5
New +$62.6K ﹤0.01% 3828

Other funds holding AIM

BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OAM
Occidental Asset Management Burlingame, California $844M AUM 20.95% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

American International Group's AIM Position: Q2 2015 in Review

American International Group sold out of AIM ImmunoTech (AIM) in Q2 2015, closing a stake of 5 shares — an estimated $66.1K sold.

American International Group first reported a position in AIM in Q1 2015 and held it in 1 quarter. The position peaked at $66.1K in Q1 2015. 14 funds tracked by Wall St. Rank hold AIM as of Q2 2015.

  • American International Group reported no remaining AIM ImmunoTech position as of Q2 2015 after selling out during the quarter.
  • American International Group sold 5 AIM ImmunoTech shares in Q2 2015, an estimated $66.1K.
  • American International Group first reported a position in AIM ImmunoTech in Q1 2015 and held it in 1 quarter.
  • American International Group's AIM ImmunoTech position peaked at $66.1K in Q1 2015.
  • 14 funds tracked by Wall St. Rank held AIM ImmunoTech as of Q2 2015.

Based on American International Group's 13F filing for Q2 2015, filed 12 Aug 2015.